59/100 C · Elevated risk
No major risk flags in the public sources we cover Indicative TraceComp estimate from public sources — an automated indicator, not a credit decision, a completed due-diligence check, or a guarantee. Verify against the official register.

ℹ️ No matches surfaced in the limited public sources we cover (sanctions, screening, insolvency, control). This is an automated indicator — not an exhaustive check, a credit decision, or a guarantee, and absence of a match does not mean none exists. Verify against the official register.

Think this is wrong? This is an automated estimate — request a human review or correction.

Drip OTC UAB

Active Uždaroji akcinė bendrovė Active for 4 years

Uždaroji akcinė bendrovė · RC 306005092 · Active since 2022

C

Overview

Drip OTC UAB is an uždaroji akcinė bendrovė registered in Lithuania, since 2022. With reported revenue of 122K EUR in 2022. Its TraceComp score of 59 (C) indicates elevated risk requiring further due diligence.

Company Information

Registration Number
306005092
Legal Form
Uždaroji akcinė bendrovė
Registered
2022-02-07

Financial Profile

Latest filed accounts: FY 2022 · most recent available in public filings

Revenue (2022) 121,703 EUR
Net Income -69,610 EUR
Total Assets 957,329 EUR
Altman Z -0.02 distress

Multi-year financials & ratios

1 year of filed accounts on file — full balance sheets, current ratio, debt-to-equity, net margin and the Altman-Z distress trend.

What’s in the full report

  • Financial statements — revenue, assets, equity & margins for every year on file (multi-year trend where available)
  • Key ratios & credit score — liquidity, leverage & profitability ratios plus our 0–100 score with a factor-by-factor breakdown
  • Insolvency & legal events — collective proceedings and adverse filings (where on record)
  • Charges & secured lending — registered charges and the creditors entitled (where filed)
  • Sanctions & screening — company-level watchlist & adverse signals
  • Sector benchmark & peers — how the company compares to its sector and nearest peers
  • Innovation & EU funding — patents, research output & EU research funding received (where applicable)
Instant access · 30-day access · no subscription · official public-register data only See a sample report → · Digital report delivered on payment; the 14-day withdrawal right is waived once opened (see Terms).

Risk Signals

No adverse legal events have been recorded for this company.

  • Net loss reported in FY 2022
  • Altman Z-Score in the distress zone — elevated insolvency risk on the model

Data Sources & Freshness

Data sourced from: bulk register.